Tag Archives: Shashank Deshpande

Boehringer Ingelheim and LEO Pharma Join Forces to Globalize SPEVIGO® Treatment for Generalized Pustular Psoriasis (GPP)

(IN BRIEF) Boehringer Ingelheim and LEO Pharma have agreed on a global license and transfer deal for SPEVIGO® (spesolimab), an antibody that blocks the IL‑36 receptor to treat generalized pustular psoriasis (GPP). LEO Pharma will assume worldwide commercialization and clinical development, harnessing … Read the full press release